Stem Cell Treatment For Stroke

by Malc on February 5, 2011

A colony of embryonic stem cells, from the H9 ...

Image via Wikipedia

The use of stem cells for stroke and other serious diseases has massive potential. In the UK, the company ReNeuron has proceeded to human clinical trials for treating ischaemic stroke – the most common type – with stem cells.

In this treatment, a stroke patient receives local anaesthetic and stem cells are injected through a tiny tube into the area of the brain affected by the stroke. In other words, the area with dead and damaged cells.

In the trial a total of twelve patients will be treated. In December 2010 the first patient to receive treatment passed 28 days without a problem, and ReNeuron were given the go-ahead to treat the other 2 patients in the first cohort. In due course the remaining 9 will receive treatment in the same way – assuming results on the other 3 continuing to be problem-free.

A successful result to this trial for stroke patients will give a huge boost to the company and to UK stem cell research in general.

Use of stem cells has massive potential. The public are wary about the implications for this type of research right now. But this concern is misplaced. In 10-20 years we will all be wondering why is took so long to get this type of therapy in mainstream use, when we see the huge amount of pain and suffering it can avoid.

ReNeuron are based in Guildford, Surrey.

Enhanced by Zemanta

Previous post: Longevity Raises Serious Issues For Insurance And Pensions

Next post: Regulation Slows Down Anti-Aging Research